Cancer Clinical Trials in the Hudson Valley
As of October 2022, patients who qualify can enroll in cancer clinical trials at NewYork-Presbyterian Hudson Valley Hospital. Our clinical trials program expands the range of cancer treatment options for patients, giving them access to cutting-edge, convenient care closer to home.
Why are Clinical Trials Important?
Clinical trials—studies that compare new and existing treatments—are key in driving cancer care and research forward. Clinical trial results have led to countless medical advances that improve the lives of patients and their families.
As a clinical trial participant, you may have the opportunity to undergo a new, innovative treatment with the potential to benefit not only you, but also future cancer patients.
Clinical Trials FAQs
If you’re interested in enrolling in a clinical trial, talking to your oncologist is a good place to start. Or, you can contact our research nurse clinical trials navigator at [email protected] or 212-342-5162 to learn more about your options.
You can also browse clinical trials on RecruitMe, a search service offered by Columbia University Irving Medical Center.
A clinical trial may give you access to a promising new treatment early in its development. No one is obligated to enroll in a clinical trial—taking part is voluntary and participants can change their minds at any time. Each clinical trial has a research team and staff that will explain its potential benefits and risks, so you can make an informed choice about participating.
With your consent, your oncologist will work with a team at Columbia University Irving Medical Center to review your medical records and determine if you meet all criteria for a clinical trial.
Though specific eligibility criteria are different for every trial, there are two types of criteria for each:
- Inclusion criteria: Conditions a patient must meet before joining the clinical trial. For example, the person’s cancer must be a specific type or stage (stage IV colon cancer or stage I kidney cancer).
- Exclusion criteria: Conditions a patient cannot have in order to join the clinical trial. For example, pregnant patients may not be eligible for a study.
You can receive clinical trial treatment or therapy right here at NewYork-Presbyterian Hudson Valley Hospital. If there is a study that better suits your needs at another campus, such as NewYork-Presbyterian/Columbia University Irving Medical Center, your clinical trial navigator will let you know.
About Our Cancer Clinical Trials Program
In 2014, the National Cancer Institute (NCI) awarded grants to researchers across the country to conduct multi-site cancer clinical trials and cancer care delivery research studies in their local areas. The grants were awarded under the NCI Community Oncology Research Program (NCORP), a national network of investigators, cancer care providers, academic institutions, and other organizations that serve diverse populations in community-based healthcare practices throughout the United States.
The Herbert Irving Comprehensive Cancer Center of NewYork-Presbyterian/Columbia was one of the first sites to receive NCORP status. The center has since expanded its program to other sites—now including NewYork-Presbyterian Hudson Valley—with the goal of making clinical trials more accessible to patients in their own communities.